20
Curia Italy Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is ARGATROBAN, with a corresponding US DMF Number 20760.
Remarkably, this DMF maintains an Active status since its submission on August 07, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 18, 2013, and payment made on October 25, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II